Summary

China has a rapidly aging population, and diabetes is more prevalent among older individuals. As the population ages, there is a higher likelihood of diabetes diagnosis and management, leading to an increased need for blood glucose monitoring devices among the elderly. According to the World Health Organization (WHO), about 110 million people in China have diabetes. This is almost 10% of all adults in the country. China is undergoing rapid urbanization, which is also a risk factor for diabetes. Urban populations are more likely to have unhealthy lifestyles, such as a lack of physical activity and a diet high in processed foods and sugary drinks. Diabetes is a major economic burden in China. In 2022, the economic burden of diabetes was estimated to be $249 billion, or 3.3% of China's GDP. This is expected to increase to $438 billion by 2045, or 4.6% of China's GDP. China needs to expand awareness campaigns about diabetes and its prevention. These campaigns should be targeted at the general population, as well as at people who are at high risk of developing the disease. These campaigns should focus on educating people about the risk factors for diabetes, the signs and symptoms of the disease, and the importance of early diagnosis and treatment. The Chinese government is committed to addressing the diabetes epidemic. This is evidenced by the National Action Plan for Diabetes Prevention and Control, which was launched in 2017. Primary care is the foundation of the healthcare system, and it is essential for providing early detection and management of diabetes. China needs to invest in training primary care providers to diagnose and manage diabetes, and to make it easier for people to access primary care services. Healthy lifestyles are the best way to prevent diabetes. China needs to promote healthy eating, physical activity, and weight management. This can be done through education campaigns, community programs, and policy changes.

According to the research report "China Blood Glucose Monitoring Devices Market Overview, 2028," published by Bonafide Research, the China Blood Glucose Monitoring Devices market was valued more than USD 900 Million in 2022. There is a trend toward the integration of blood glucose monitoring devices with mobile health platforms and applications. These digital solutions offer features such as data tracking, real-time monitoring, and connectivity with healthcare providers, enhancing the overall management of diabetes. Non-invasive or minimally invasive blood glucose monitoring technologies have been a focus of research and development. The trend is toward devices that reduce discomfort for users, promoting regular monitoring and improving overall adherence to monitoring routines. Blood glucose monitoring functionalities are increasingly integrated into smart wearables, such as smartwatches and fitness trackers. This trend aligns with the broader consumer interest in health and fitness tracking, providing users with a more holistic approach to monitoring their well-being. The adoption of telehealth services, particularly in the wake of the COVID-19 pandemic, has accelerated in China. Blood glucose monitoring devices that support remote monitoring and telehealth consultations have become more relevant, offering convenience and accessibility to individuals with diabetes. There is a trend toward designing blood glucose monitoring devices that are user-friendly and customizable. Devices with easy-to-read displays, intuitive interfaces, and customizable features cater to the diverse preferences and needs of the Chinese population. Pediatric diabetes management has gained attention, leading to the development of blood glucose monitoring devices specifically designed for children. Child-friendly designs, smaller form factors, and educational resources for parents contribute to effective pediatric diabetes care. The integration of artificial intelligence (AI) for data analysis and interpretation is becoming more prevalent. AI algorithms can provide insights into glucose patterns, offer predictive analytics, and assist healthcare providers and users in making more informed decisions.

The China Blood Glucose Monitoring Devices Market, the Continuous Blood Glucose Monitoring Devices segment is anticipated to witness the highest Compound Annual Growth Rate (CAGR) during the forecast period. Continuous Blood Glucose Monitoring (CGM) Devices offer a paradigm shift in diabetes management by providing real-time data, allowing individuals to track their glucose levels continuously without the need for frequent fingerstick tests. Technological advancements play a pivotal role in the increasing adoption of CGM devices. These innovations encompass improved sensor accuracy, longer sensor lifespans, and enhanced connectivity features. The continuous monitoring capability empowers individuals to make timely and informed decisions regarding their dietary choices, physical activity, and insulin administration, contributing to better glycemic control. The preference for CGM devices is also driven by their ability to provide early detection of fluctuations in glucose levels, enabling proactive intervention to prevent hyperglycemia or hypoglycemia. This feature is especially crucial for individuals with diabetes who seek a more comprehensive and personalized approach to managing their condition. urthermore, the growing awareness of the benefits associated with continuous monitoring, both among healthcare professionals and individuals with diabetes, is propelling the demand for CGM devices. These devices are particularly favored by those who require tight glycemic control, such as individuals with type 1 diabetes or those with advanced stages of type 2 diabetes.

Based on end user the market is divided into Hospitals, Home Care and Diagnostic Centers. Firstly, hospitals serve as central hubs for comprehensive healthcare services, making them primary settings for blood glucose monitoring, especially in critical care and inpatient environments. The Hospitals segment encompasses a wide range of services, including emergency departments, specialized diabetes clinics, and general wards, where blood glucose levels need to be closely monitored for individuals with diabetes. The demand for blood glucose monitoring devices in hospitals is also driven by the need for accurate and immediate assessments. Hospitals often require point-of-care testing (POCT) for rapid results, influencing the choice of monitoring devices that can provide timely information to guide clinical decision-making. In critical care units, continuous glucose monitoring (CGM) devices may be preferred for their ability to offer real-time data and support precise glycemic control. Hospitals in China play a crucial role in managing diabetes-related complications and emergencies. Blood glucose monitoring devices are essential tools in emergency departments for assessing and managing individuals presenting with acute diabetes-related issues. The Hospitals segment thus becomes a focal point for the use of diverse monitoring technologies to address the varying needs of patients.

Considered in this report:
• Geography: China
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• China Blood Glucose Monitoring Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Self-monitoring Devices
• Continuous Blood Glucose Monitoring Devices

By End User
• Hospitals
• Home Care
• Diagnostic Centers

By Indication
• Diabetes
• Pregnancy
• Cardiovascular Disorders & Hypertension
• Cancer
• Respiratory Diseases
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Blood Glucose Monitoring Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents